These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 27057627)

  • 21. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
    Kimura M; Tojo T; Naito H; Nagata Y; Kawai N; Taniguchi S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study.
    Sun Z; Sui X; Yang F; Wang J
    Lung Cancer; 2019 Mar; 129():98-106. PubMed ID: 30545693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer.
    Xu Z; Ma Z; Zhao F; Li J; Kong R; Li S; Jiang J; Kang H; Liu D
    Sci Rep; 2024 Oct; 14(1):24206. PubMed ID: 39406938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current readings: the most influential and recent studies regarding resection of lung cancer in m1a disease.
    Mordant P; Rivera C; Legras A; Le Pimpec Barthes F; Riquet M
    Semin Thorac Cardiovasc Surg; 2013; 25(3):251-5. PubMed ID: 24331148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?
    Dai C; Ren Y; Xie D; Zheng H; She Y; Fei K; Jiang G; Chen C
    J Thorac Oncol; 2016 Oct; 11(10):1745-54. PubMed ID: 27567989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA; Ou SH; Ziogas A; Anton-Culver H
    Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively.
    Hu J; Chen Y; Zhu X; Ma Q; Zhang J; Jiang G; Zhang P
    BMC Cancer; 2021 Apr; 21(1):445. PubMed ID: 33888088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.
    Lv X; Cao J; Dai X; Rusidanmu A
    Thorac Cancer; 2018 Aug; 9(8):1026-1031. PubMed ID: 29927089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm.
    Cao J; Xu J; He Z; Yuan P; Huang S; Lv W; Hu J
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):796-805.e4. PubMed ID: 29716729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
    Wei S; Xie M; Tian J; Song X; Wu B; Liu L
    Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.
    Kumar A; Xu B; Srinivasan D; Potter AL; Raman V; Lanuti M; Yang CJ; Auchincloss HG
    Chest; 2024 Mar; 165(3):725-737. PubMed ID: 37544427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
    Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
    Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.
    Shen H; Cao Y; Li X; Tan Y; Chen J; Yang Z; Kong Y; Yuan Y
    Medicine (Baltimore); 2016 May; 95(21):e3800. PubMed ID: 27227958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Intervention for Non-Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004.
    Iida T; Shiba M; Yoshino I; Miyaoka E; Asamura H; Date H; Okumura M; Tada H; Nakanishi Y; Dosaka-Akita H; Kobayashi H; Takahashi K; Inoue M; Yokoi K;
    J Thorac Oncol; 2015 Jul; 10(7):1076-82. PubMed ID: 26134225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination.
    Liu B; Liu L; Hu M; Qian K; Li Y
    Thorac Cancer; 2016 Sep; 7(5):549-555. PubMed ID: 27766779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.